Carbamazepine Tablet
Product Images NDC 43063-328

4 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 43063-328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical Structure (Carbamazepine 01)
Chemical structure of carbamazepine, showing its dibenzazepine tricyclic ring system with a carboxamide group attached.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A table titled 'Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' showing comparative risk data for placebo versus drug patients across three indication categories: Epilepsy, Psychiatric, and Other. The table includes columns for events per 1,000 patients, relative risk of events, and risk difference for additional drug patient events.*
FDA Label Image

Table (Table 2)

Table (Table 2)
Dosage information table for Carbamazepine tablets, extended-release tablets (XR), and suspension across indications such as epilepsy and trigeminal neuralgia. The table lists initial doses, subsequent doses, and maximum daily doses by age groups and condition, including specific dosing increments and frequency guidelines.*
FDA Label Image

43063328 Label (43063328)

43063328 Label (43063328)
Label for Carbamazepine USP 200 mg oral tablets, manufactured by PD-Rx Pharmaceuticals, Inc. The label states the product contains 30 tablets and includes warnings to keep out of reach of children and directs to the package insert for dosage and storage. The label also displays the NDC 43063-328-30, lot number C22B20, and expiration date 03/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.